Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)
Marnix Lameijer,Tina Binderup,Mandy M. T. van Leent,Max L. Senders,Francois Fay,Joost Malkus,Brenda L. Sanchez-Gaytan,Abraham J. P. Teunissen,Nicolas Karakatsanis,Philip Robson,Xianxiao Zhou,Yuxiang Ye,Gregory Wojtkiewicz,Jun Tang,Tom T. P. Seijkens,Jeffrey Kroon,Erik S. G. Stroes,Andreas Kjaer,Jordi Ochando,Thomas Reiner,Carlos Pérez-Medina,Claudia Calcagno,Edward A. Fisher,Bin Zhang,Ryan E. Temel,Filip K. Swirski,Matthias Nahrendorf,Zahi A. Fayad,Esther Lutgens,Willem J. M. Mulder,Raphaël Duivenvoorden
IF: 28.1
2018-01-01
Nature Biomedical Engineering
Abstract:In the version of this Article originally published, the surname of the author Edward A. Fisher was spelt incorrectly as ‘Fischer’. This has now been corrected.